The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Gastritis Drugs Market Research Report 2025
Synopsis
The global Chronic Gastritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Gastritis Drugs include GSK, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Gastritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gastritis Drugs.
Report Scope
The Chronic Gastritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gastritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Gastritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Chinese Patent Medicine
Western Medicine
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Gastritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Gastritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Chronic Gastritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Gastritis Drugs include GSK, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Gastritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gastritis Drugs.
Report Scope
The Chronic Gastritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gastritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Gastritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Chinese Patent Medicine
Western Medicine
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Gastritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Gastritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chronic Gastritis Drugs Market Overview
1.1 Product Overview and Scope of Chronic Gastritis Drugs
1.2 Chronic Gastritis Drugs Segment by Type
1.2.1 Global Chronic Gastritis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Chinese Patent Medicine
1.2.3 Western Medicine
1.3 Chronic Gastritis Drugs Segment by Application
1.3.1 Global Chronic Gastritis Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Supermarket
1.3.5 Others
1.4 Global Chronic Gastritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Chronic Gastritis Drugs Revenue 2019-2030
1.4.2 Global Chronic Gastritis Drugs Sales 2019-2030
1.4.3 Global Chronic Gastritis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chronic Gastritis Drugs Market Competition by Manufacturers
2.1 Global Chronic Gastritis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chronic Gastritis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chronic Gastritis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Chronic Gastritis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Gastritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Gastritis Drugs, Product Type & Application
2.7 Chronic Gastritis Drugs Market Competitive Situation and Trends
2.7.1 Chronic Gastritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Gastritis Drugs Players Market Share by Revenue
2.7.3 Global Chronic Gastritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Gastritis Drugs Retrospective Market Scenario by Region
3.1 Global Chronic Gastritis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chronic Gastritis Drugs Global Chronic Gastritis Drugs Sales by Region: 2019-2030
3.2.1 Global Chronic Gastritis Drugs Sales by Region: 2019-2024
3.2.2 Global Chronic Gastritis Drugs Sales by Region: 2025-2030
3.3 Global Chronic Gastritis Drugs Global Chronic Gastritis Drugs Revenue by Region: 2019-2030
3.3.1 Global Chronic Gastritis Drugs Revenue by Region: 2019-2024
3.3.2 Global Chronic Gastritis Drugs Revenue by Region: 2025-2030
3.4 North America Chronic Gastritis Drugs Market Facts & Figures by Country
3.4.1 North America Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chronic Gastritis Drugs Sales by Country (2019-2030)
3.4.3 North America Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Gastritis Drugs Market Facts & Figures by Country
3.5.1 Europe Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chronic Gastritis Drugs Sales by Country (2019-2030)
3.5.3 Europe Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Chronic Gastritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chronic Gastritis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Chronic Gastritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chronic Gastritis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Gastritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chronic Gastritis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Gastritis Drugs Sales by Type (2019-2030)
4.1.1 Global Chronic Gastritis Drugs Sales by Type (2019-2024)
4.1.2 Global Chronic Gastritis Drugs Sales by Type (2025-2030)
4.1.3 Global Chronic Gastritis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Chronic Gastritis Drugs Revenue by Type (2019-2030)
4.2.1 Global Chronic Gastritis Drugs Revenue by Type (2019-2024)
4.2.2 Global Chronic Gastritis Drugs Revenue by Type (2025-2030)
4.2.3 Global Chronic Gastritis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Chronic Gastritis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chronic Gastritis Drugs Sales by Application (2019-2030)
5.1.1 Global Chronic Gastritis Drugs Sales by Application (2019-2024)
5.1.2 Global Chronic Gastritis Drugs Sales by Application (2025-2030)
5.1.3 Global Chronic Gastritis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Chronic Gastritis Drugs Revenue by Application (2019-2030)
5.2.1 Global Chronic Gastritis Drugs Revenue by Application (2019-2024)
5.2.2 Global Chronic Gastritis Drugs Revenue by Application (2025-2030)
5.2.3 Global Chronic Gastritis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Chronic Gastritis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Chronic Gastritis Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Chronic Gastritis Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Chronic Gastritis Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Chronic Gastritis Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Procter & Gamble
6.5.1 Procter & Gamble Corporation Information
6.5.2 Procter & Gamble Description and Business Overview
6.5.3 Procter & Gamble Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Procter & Gamble Chronic Gastritis Drugs Product Portfolio
6.5.5 Procter & Gamble Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Perrigo Chronic Gastritis Drugs Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Chronic Gastritis Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Chronic Gastritis Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Nestle
6.10.1 Nestle Corporation Information
6.10.2 Nestle Description and Business Overview
6.10.3 Nestle Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nestle Chronic Gastritis Drugs Product Portfolio
6.10.5 Nestle Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Chronic Gastritis Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Boehringer Ingelheim Chronic Gastritis Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Reckitt Benckiser
6.12.1 Reckitt Benckiser Corporation Information
6.12.2 Reckitt Benckiser Chronic Gastritis Drugs Description and Business Overview
6.12.3 Reckitt Benckiser Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Reckitt Benckiser Chronic Gastritis Drugs Product Portfolio
6.12.5 Reckitt Benckiser Recent Developments/Updates
6.13 Purdue Pharma
6.13.1 Purdue Pharma Corporation Information
6.13.2 Purdue Pharma Chronic Gastritis Drugs Description and Business Overview
6.13.3 Purdue Pharma Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Purdue Pharma Chronic Gastritis Drugs Product Portfolio
6.13.5 Purdue Pharma Recent Developments/Updates
6.14 China Resources Sanjiu Pharmaceutical
6.14.1 China Resources Sanjiu Pharmaceutical Corporation Information
6.14.2 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.14.3 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.14.5 China Resources Sanjiu Pharmaceutical Recent Developments/Updates
6.15 Sunflower Pharmaceutical
6.15.1 Sunflower Pharmaceutical Corporation Information
6.15.2 Sunflower Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.15.3 Sunflower Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sunflower Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.15.5 Sunflower Pharmaceutical Recent Developments/Updates
6.16 Livzon Pharmaceutical
6.16.1 Livzon Pharmaceutical Corporation Information
6.16.2 Livzon Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.16.3 Livzon Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Livzon Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.16.5 Livzon Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Gastritis Drugs Industry Chain Analysis
7.2 Chronic Gastritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Gastritis Drugs Production Mode & Process
7.4 Chronic Gastritis Drugs Sales and Marketing
7.4.1 Chronic Gastritis Drugs Sales Channels
7.4.2 Chronic Gastritis Drugs Distributors
7.5 Chronic Gastritis Drugs Customers
8 Chronic Gastritis Drugs Market Dynamics
8.1 Chronic Gastritis Drugs Industry Trends
8.2 Chronic Gastritis Drugs Market Drivers
8.3 Chronic Gastritis Drugs Market Challenges
8.4 Chronic Gastritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chronic Gastritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chronic Gastritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chronic Gastritis Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chronic Gastritis Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Chronic Gastritis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chronic Gastritis Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chronic Gastritis Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chronic Gastritis Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chronic Gastritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Gastritis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Gastritis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Gastritis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Gastritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Gastritis Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Gastritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chronic Gastritis Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Chronic Gastritis Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Chronic Gastritis Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Chronic Gastritis Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Chronic Gastritis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chronic Gastritis Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Chronic Gastritis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chronic Gastritis Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Chronic Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chronic Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Chronic Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Chronic Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chronic Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chronic Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chronic Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Chronic Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Chronic Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chronic Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chronic Gastritis Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chronic Gastritis Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Chronic Gastritis Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Chronic Gastritis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chronic Gastritis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chronic Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chronic Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Chronic Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Chronic Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chronic Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Chronic Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Chronic Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chronic Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chronic Gastritis Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Chronic Gastritis Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Chronic Gastritis Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Chronic Gastritis Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Chronic Gastritis Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chronic Gastritis Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chronic Gastritis Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Chronic Gastritis Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Chronic Gastritis Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Chronic Gastritis Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Chronic Gastritis Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Chronic Gastritis Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Chronic Gastritis Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Chronic Gastritis Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Chronic Gastritis Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chronic Gastritis Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chronic Gastritis Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Chronic Gastritis Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Chronic Gastritis Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Chronic Gastritis Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Chronic Gastritis Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Chronic Gastritis Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Chronic Gastritis Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bayer Chronic Gastritis Drugs Product
Table 89. Bayer Recent Developments/Updates
Table 90. Procter & Gamble Corporation Information
Table 91. Procter & Gamble Description and Business Overview
Table 92. Procter & Gamble Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Procter & Gamble Chronic Gastritis Drugs Product
Table 94. Procter & Gamble Recent Developments/Updates
Table 95. Perrigo Corporation Information
Table 96. Perrigo Description and Business Overview
Table 97. Perrigo Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Perrigo Chronic Gastritis Drugs Product
Table 99. Perrigo Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Abbott Chronic Gastritis Drugs Product
Table 104. Abbott Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sanofi Chronic Gastritis Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Teva Pharmaceutical Corporation Information
Table 111. Teva Pharmaceutical Description and Business Overview
Table 112. Teva Pharmaceutical Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutical Chronic Gastritis Drugs Product
Table 114. Teva Pharmaceutical Recent Developments/Updates
Table 115. Nestle Corporation Information
Table 116. Nestle Description and Business Overview
Table 117. Nestle Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Nestle Chronic Gastritis Drugs Product
Table 119. Nestle Recent Developments/Updates
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Boehringer Ingelheim Chronic Gastritis Drugs Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Reckitt Benckiser Corporation Information
Table 126. Reckitt Benckiser Description and Business Overview
Table 127. Reckitt Benckiser Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Reckitt Benckiser Chronic Gastritis Drugs Product
Table 129. Reckitt Benckiser Recent Developments/Updates
Table 130. Purdue Pharma Corporation Information
Table 131. Purdue Pharma Description and Business Overview
Table 132. Purdue Pharma Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Purdue Pharma Chronic Gastritis Drugs Product
Table 134. Purdue Pharma Recent Developments/Updates
Table 135. China Resources Sanjiu Pharmaceutical Corporation Information
Table 136. China Resources Sanjiu Pharmaceutical Description and Business Overview
Table 137. China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Product
Table 139. China Resources Sanjiu Pharmaceutical Recent Developments/Updates
Table 140. Sunflower Pharmaceutical Corporation Information
Table 141. Sunflower Pharmaceutical Description and Business Overview
Table 142. Sunflower Pharmaceutical Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sunflower Pharmaceutical Chronic Gastritis Drugs Product
Table 144. Sunflower Pharmaceutical Recent Developments/Updates
Table 145. Livzon Pharmaceutical Corporation Information
Table 146. Livzon Pharmaceutical Description and Business Overview
Table 147. Livzon Pharmaceutical Chronic Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Livzon Pharmaceutical Chronic Gastritis Drugs Product
Table 149. Livzon Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Chronic Gastritis Drugs Distributors List
Table 153. Chronic Gastritis Drugs Customers List
Table 154. Chronic Gastritis Drugs Market Trends
Table 155. Chronic Gastritis Drugs Market Drivers
Table 156. Chronic Gastritis Drugs Market Challenges
Table 157. Chronic Gastritis Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Gastritis Drugs
Figure 2. Global Chronic Gastritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chronic Gastritis Drugs Market Share by Type in 2023 & 2030
Figure 4. Chinese Patent Medicine Product Picture
Figure 5. Western Medicine Product Picture
Figure 6. Global Chronic Gastritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Chronic Gastritis Drugs Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Online Supermarket
Figure 11. Others
Figure 12. Global Chronic Gastritis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chronic Gastritis Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Chronic Gastritis Drugs Sales (2019-2030) & (K Units)
Figure 15. Global Chronic Gastritis Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. Chronic Gastritis Drugs Report Years Considered
Figure 17. Chronic Gastritis Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Chronic Gastritis Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Chronic Gastritis Drugs Players: Market Share by Revenue in 2023
Figure 20. Chronic Gastritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Chronic Gastritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Chronic Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Chronic Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Chronic Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Chronic Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Chronic Gastritis Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Chronic Gastritis Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Chronic Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 43. Latin America Chronic Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Chronic Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Chronic Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Chronic Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Chronic Gastritis Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Chronic Gastritis Drugs by Type (2019-2030)
Figure 54. Global Chronic Gastritis Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Chronic Gastritis Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Chronic Gastritis Drugs by Application (2019-2030)
Figure 57. Global Chronic Gastritis Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Chronic Gastritis Drugs Value Chain
Figure 59. Chronic Gastritis Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
